# Internal Review — Claude Code

**Reviewer:** Claude Code (claude-opus-4-6)
**Paper:** apep_0341 v2
**Date:** 2026-02-17

## Summary

This revision of paper 0341 addresses feedback from the v1 external reviewers (GPT: MAJOR REVISION, Grok: MINOR REVISION, Gemini: MINOR REVISION). The paper studies whether Medicaid HCBS reimbursement rate increases expand provider supply using T-MSIS data (2018-2024) and staggered DiD.

## Key Improvements in v2

1. **Treatment validation:** External validation against ARPA spending plans for 10 treated states
2. **ARPA-era subsample:** Separate analysis of 7 post-April 2021 treatment cohorts
3. **Wild cluster bootstrap:** WCB p-values (Webb weights, 9,999 reps) for all main results
4. **Randomization inference for CS-DiD:** Fisher permutation tests for ATT
5. **Consolidation mechanism tests:** Org share and claims/provider (both null)
6. **Sensitivity analyses:** Alternative thresholds, bandwidths, median detection, state trends
7. **Literature expansion:** ~50 references including modern DiD methodology
8. **Honest reporting:** All consolidation claims corrected to reflect null results

## Remaining Concerns

1. Treatment defined from same data as outcomes — mitigated but not fully resolved
2. CI for main result is wide (not "precise null" — corrected in text)
3. Short post-treatment windows for late cohorts (Oregon: 9 months)
4. Billing NPIs as workforce proxy — acknowledged as limitation

## Verdict

The paper is ready for publication. Core finding (null supply response to rate increases) is well-supported by multiple estimators and robustness checks.
